DVT incidence: No significant difference was observed between GLP-1 receptor agonists and placebo for the DVT incidence (RR = 1.16, 95% CI = 0.78-1.72; p = 0.46; I2 = 0%) (Figure 6). The gene discussed is GLP1R; the disease is deep vein thrombosis.